17 March 2016 - Deborah Wilkes
Archived
GlaxoSmithKline has announced that Sir Andrew Witty will retire as chief executive officer on 31 March 2017, after more than three decades at the UK-based pharmaceutical company.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.